Semigran Marc 4
4 · Renovacor, Inc. · Filed Jan 26, 2022
Insider Transaction Report
Form 4
Renovacor, Inc.RCOR
Semigran Marc
Chief Medical Officer
Transactions
- Award
Stock Option
2022-01-24+34,850→ 34,850 totalExercise: $6.45Exp: 2032-01-24→ Common Stock (34,850 underlying) - Award
Common Stock
2022-01-24+17,425→ 52,651 total
Footnotes (2)
- [F1]These restricted stock units will vest in four equal annual installments beginning on January 24, 2023, subject to continued service with the Company.
- [F2]The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in equal monthly installments on the24th of each month for the remaining 36months, subject to the continuous service of the Reporting Person on such vesting date.